Caribou Biosciences Inc.

NASDAQ: CRBU · Real-Time Price · USD
1.97
-0.03 (-1.50%)
At close: Aug 15, 2025, 3:59 PM
1.98
0.51%
After-hours: Aug 15, 2025, 05:38 PM EDT

Caribou Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
16.29M 51.16M 58.34M 240.42M
Short-Term Investments
193.24M 277.67M 189.32M 135.41M
Long-Term Investments
49.13M 51.33M 77.07M 45.3M
Other Long-Term Assets
5.52M 1.59M 1.54M 975K
Receivables
3.25M 3.86M 4.66M 8.12M
Inventory
n/a n/a -62.57M -31.11M
Other Current Assets
1.78M 1.22M 63.69M 31.78M
Total Current Assets
219.38M 338.84M 260.25M 391.19M
Property-Plant & Equipment
39.29M 40.45M 34.91M 4.89M
Goodwill & Intangibles
n/a n/a -10.5M -2.85M
Total Long-Term Assets
93.94M 93.37M 113.52M 51.16M
Total Assets
313.31M 432.21M 373.76M 442.36M
Account Payables
2.48M 3.12M 1.15M 3.99M
Deferred Revenue
3.13M 2.85M 9.94M 8.7M
Short-Term Debt
1.44M n/a n/a 259K
Other Current Liabilities
235K 10.62M 7.12M 4.75M
Total Current Liabilities
30.65M 28.3M 28.13M 25.83M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
785K 2.94M 1.65M 6.19M
Total Long-Term Liabilities
29.71M 35.51M 44.77M 28.7M
Total Liabilities
60.36M 63.81M 72.89M 54.53M
Total Debt
26.49M 27.11M 27.75M 259K
Common Stock
9K 8K 6K 6K
Retained Earnings
-448.39M -299.29M -197.22M -97.79M
Comprehensive Income
255K 30K -1.52M -135K
Shareholders Equity
252.95M 368.4M 300.87M 387.82M
Total Investments
242.37M 329M 266.4M 180.71M